Navigation Links
Northwest Biotherapeutics, Inc. Announces Appointment of Chief Financial Officer

BETHESDA, Md., Oct. 2 /PRNewswire-FirstCall/ -- Northwest Biotherapeutics, Inc. (OTC Bulletin Board: NWBO; AIM: NWBT and NWBS) announced today that Anthony P. Deasey, 58, has been appointed as the Company's Senior Vice President of Finance and Chief Financial Officer, and has been elected to the Board of Directors.

Prior to joining NWBT, from November 2000 to September 2007 Mr. Deasey served as Executive Vice President, Chief Financial and Chief Operating Officer of Celsion Corporation, a biotechnology company headquartered in Columbia, Maryland. At Celsion, Mr. Deasey played a key role in transitioning Celsion from a medical device to an oncology drug development company, and acquired substantial experience with oncology regulatory and market factors. In addition to Celsion, Mr. Deasey previously served as Chief Financial Officer of two public companies with domestic and international operations and a diverse range of products with up to $800 million in revenues.

"We are very pleased to announce the appointment of Tony as our Chief Financial Officer," said Alton Boynton, PhD, President and Chief Executive Officer of Northwest Biotherapeutics. "As we are in the process of establishing international operations and accelerating our pivotal studies in the United States, Tony's extensive financial, operational and management experience, and his familiarity with the oncology sector, will be a valuable addition to our team."


Northwest Biotherapeutics, Inc. is a US-based biotechnology company focused on developing immunotherapy products that treat cancers more effectively than current treatments, without toxicity, and on a cost-effective basis.

The Company has two lead product candidates:

1. DCVax(R)-Brain, a personalized dendritic cell vaccine for treatment of

Glioblastoma multiforme; and

2. DCVax(R)-Prostate, a personalized dendritic cell vaccine for treatment

of hormone independent, non-metastatic prostate cancer.

The Company also has a robust pipeline of additional products cleared by FDA for early stage clinical trials in five other cancers beyond brain and prostate cancers.

For further information, please visit the company web site at


Statements made in this news release that are not historical facts are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Words such as "expects," "believes," "intends," and similar expressions are intended to identify forward-looking statements. Actual results may differ materially from those projected in any forward-looking statement. Specifically, there are a number of important factors that could cause actual results to differ materially from those anticipated, such as risks related to the uncertainties of litigation in general and, specifically litigation involving intellectual property claims and securities class action claims that have been filed against the Company. Additional information on these and other factors which could affect the company's results is included in its Securities and Exchange Commission ("SEC") filings and its filings pursuant to its listing on the Alternative Investment Market of the London Stock Exchange ("AIM"). Finally, there may be other factors not mentioned above or included in the company's SEC filings and/or AIM filings that may cause actual results to differ materially from those projected in any forward-looking statement. You should not place undue reliance on any forward-looking statements. The company assumes no obligation to update any forward-looking statements as a result of new information, future events or developments, except as required by securities laws.

SOURCE Northwest Biotherapeutics, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. Northwestern Mutual, American Family make Computerworlds best IT workplaces
2. Northwestern adds to its Imago microscope
3. Imago microscope leads to Northwestern research advance
4. Northwest Wis. Manufacturing Outreach Center honored by DOC, NIST
5. Speaker announces business members of IT Task Force
6. Doyle announces technology tax credits for Berbee
7. Doyle announces new energy, global warming policies
8. Doyle announces $80M renewable energy strategy
9. GE announces first installation of Discovery VCT
10. UWM announces winners of RGI awards
11. Third Wave announces two senior management appointments
Post Your Comments:
(Date:11/25/2015)... Muncie, IN (PRWEB) , ... November 25, 2015 ... ... Aeronautics (AMA) and the Organization of Black Aerospace Professionals (OPBAP) has been formalized ... Mathewson and other AMA team leaders met with OPBAP leaders Capt. Karl Minter ...
(Date:11/25/2015)... Francisco, CA (PRWEB) , ... November 25, 2015 ... ... microbial genomics company uBiome, were featured on AngelList early in their initial angel ... launching an AngelList syndicate for individuals looking to make early stage investments in ...
(Date:11/24/2015)... Calif. , Nov. 24, 2015 Cepheid ... will be speaking at the following conference, and invited ... New York, NY      Tuesday, December 1, 2015 ... New York, NY      Tuesday, December 1, 2015 ... Jaffray Healthcare Conference, New York, NY ...
(Date:11/24/2015)... ... November 24, 2015 , ... Copper is ... it is bound to proteins, copper is also toxic to cells. With a ... Polytechnic Institute (WPI) will conduct a systematic study of copper in the bacteria ...
Breaking Biology Technology:
(Date:11/20/2015)... NXTD ) ("NXT-ID" or the ... mobile commerce market and creator of the Wocket® smart ... recently interviewed on The RedChip Money Report ... on Bloomberg Europe , Bloomberg Asia, Bloomberg Australia, ... NXTD ) ("NXT-ID" or the "Company"), a biometric authentication ...
(Date:11/18/2015)... 2015  As new scientific discoveries deepen our understanding ... healthcare providers face challenges in better using that knowledge ... addition, as more children continue to survive pediatric cancer, ... old age. John M. Maris, M.D ., ... Philadelphia (CHOP) . --> John M. ...
(Date:11/17/2015)... 17, 2015 Paris ... --> Paris , qui s,est ... DERMALOG, le leader de l,innovation biométrique, a inventé le ... et empreintes sur la même surface de balayage. Jusqu,ici, ... l,autre pour les empreintes digitales. Désormais, un seul scanner ...
Breaking Biology News(10 mins):